Research ArticleClinical Studies

Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma

SHOZO MORI, TAKU AOKI, YUHKI SAKURAOKA, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, YUKIHIRO ISO and KEIICHI KUBOTA
Anticancer Research March 2021, 41 (3) 1629-1639; DOI: https://doi.org/10.21873/anticanres.14925

Article Information

vol. 41 no. 3 1629-1639
DOI 
https://doi.org/10.21873/anticanres.14925
PubMed 
33788759
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 21, 2021
  • Revision received February 1, 2021
  • Accepted February 2, 2021
  • Published online March 3, 2021.
Copyright & Usage 
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. SHOZO MORI⇑,
  2. TAKU AOKI,
  3. YUHKI SAKURAOKA,
  4. TAKAYUKI SHIMIZU,
  5. TAKAMUNE YAMAGUCHI,
  6. KYUNG-HWA PARK,
  7. TAKATSUGU MATSUMOTO,
  8. TAKAYUKI SHIRAKI,
  9. YUKIHIRO ISO and
  10. KEIICHI KUBOTA
  1. Department of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan
  1. Correspondence to: Shozo Mori, MD, Ph.D., Department of Gastroenterological Surgery, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi, 321-0293, Japan. Tel: +81 282872158, Fax: +81 282866317, e-mail: s-mori{at}dokkyomed.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma
SHOZO MORI, TAKU AOKI, YUHKI SAKURAOKA, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, YUKIHIRO ISO, KEIICHI KUBOTA
Anticancer Research Mar 2021, 41 (3) 1629-1639; DOI: 10.21873/anticanres.14925
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords